Safeguarding Personal Data: myMedidata’s Approach to Protecting Personally Identifiable Information (PII)

Data collection is central to the success of clinical trial programs, and there are a multitude of ways in which data is collected by all parties involved in a trial. Trust in the systems that help efficiently and effectively execute these processes is essential for patients, sponsors, and sites alike. This white paper will take a closer look at how Medidata manages patient data shared through myMedidata for patients participating in global trials with varied regional regulations, outlining how the use of a myMedidata account adheres to GCP guidelines and follows ALCOA+ principles. It will also examine how that data is stored and accessed following compliance standards to ensure continuous and unquestionable data integrity.